Fidelity Investments’s Strongbridge Biopharma plc. SBBP Stock Holding History

Fidelity Investments’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-650	Closed	-$1K	–	5237
2021 Q3	$1K	Buy	+650	New	+$1.51K	﹤0.01%	4252
2021 Q1	–	Sell	-450	Closed	-$1K	–	4748
2020 Q4	$1K	Buy	+450	New	+$1.08K	﹤0.01%	3775
2020 Q1	–	Sell	-1,000	Closed	-$2K	–	4457
2019 Q4	$2K	Buy	+1,000	New	+$1.92K	﹤0.01%	3610
2019 Q3	–	Sell	-588	Closed	-$2K	–	4379
2019 Q2	$2K	Buy	+588	New	+$2.16K	﹤0.01%	3570

Fidelity Investments's SBBP Position: Q4 2021 in Review

Fidelity Investments sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 650 shares — an estimated $1K sold.

Fidelity Investments first reported a position in SBBP in Q2 2019 and held it in 4 quarters. The position peaked at $2K in Q4 2019. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

Fidelity Investments reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
Fidelity Investments sold 650 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $1K.
Fidelity Investments first reported a position in Strongbridge Biopharma plc. in Q2 2019 and held it in 4 quarters.
Fidelity Investments's Strongbridge Biopharma plc. position peaked at $2K in Q4 2019.
0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Fidelity Investments's 13F filing for Q4 2021, filed 14 Feb 2022.